| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects. | Aliment Pharmacol Ther | 2015 | 1.18 |
| 2 | Molecular characterization of the ERGIC-53 gene in two Japanese patients with combined factor V-factor VIII deficiency. | Ann Hematol | 2001 | 0.80 |